HPS Pharmacies wish to give notice that Sanofi-Aventis is experiencing a supply interruption for Stemetil® ampoules as follows:
Stemetil® Injection Ampoule
Prochlorperazine mesilate 12.5mg/1mL
Normal supplies of Stemetil® ampoules are expected to return in late April 2021. Internationally registered brands of this medicine may be accessed via the Special Access Scheme (SAS), if necessary. Please note that SAS alternatives are subject to a longer lead-time and different pricing as they must be sourced internationally.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Sanofi-Aventis on 1800 818 806 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates